Serum 25-Hydroxyvitamin D Concentrations and Ischemic Stroke and Its Subtypes
dc.rights.license | open | en_US |
dc.contributor.author | LARSSON, S. C. | |
dc.contributor.author | TRAYLOR, M. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | MISHRA, Aniket | |
dc.contributor.author | HOWSON, J. M. M. | |
dc.contributor.author | MICHAELSSON, K. | |
dc.contributor.author | MARKUS, H. S. | |
dc.date.accessioned | 2020-11-30T08:53:20Z | |
dc.date.available | 2020-11-30T08:53:20Z | |
dc.date.issued | 2018-10 | |
dc.identifier.issn | 0039-2499 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/21248 | |
dc.description.abstractEn | Background and Purpose- Observational studies have reported increased risk of ischemic stroke among individuals with low serum 25-hydroxyvitamin D (S-25OHD) concentrations but uncertainty remains about the causality of this association. We sought to determine whether S-25OHD concentrations are causally associated with ischemic stroke and its subtypes using Mendelian randomization. Methods- We used summary-level data for ischemic stroke (34 217 cases and 404 630 noncases) from the MEGASTROKE consortium. As instruments, we used 6 single nucleotide polymorphisms, explaining 7.5% of the variance in S-25OHD, previously identified to be associated with S-25OHD concentrations in the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits consortium (n=79 366). The analyses were conducted using the inverse-variance-weighted method and complemented with the weighted median, heterogeneity-penalized, and Mendelian randomization-Egger approaches. Results- Genetically higher S-25OHD concentration was not associated with ischemic stroke. The odds ratios (95% CI) per genetically predicted 1-SD ( approximately 18 nmol/L) increase in S-25OHD concentrations, based on all 6 single nucleotide polymorphisms, were 1.01 (0.94-1.08; P=0.84) for all ischemic stroke, 0.94 (0.80-1.11; P=0.49) for large artery stroke, 0.95 (0.82-1.11; P=0.55) for small vessel stroke, and 1.02 (0.90-1.16; P=0.74) for cardioembolic stroke. The results were similar in sensitivity analyses. Conclusions- These findings provide no support that higher S-25OHD concentrations are causally associated with any ischemic stroke subtype. Thus, vitamin D supplementation will unlikely reduce the risk of ischemic stroke in the general population. | |
dc.language.iso | EN | en_US |
dc.subject.en | VINTAGE | |
dc.title.en | Serum 25-Hydroxyvitamin D Concentrations and Ischemic Stroke and Its Subtypes | |
dc.title.alternative | Stroke | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1161/strokeaha.118.022242 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 30355092 | en_US |
bordeaux.journal | Stroke | en_US |
bordeaux.page | 2508-2511 | en_US |
bordeaux.volume | 49 | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.issue | 10 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.team | VINTAGE | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-03030443 | |
hal.version | 1 | |
hal.date.transferred | 2020-11-30T08:53:27Z | |
hal.export | true | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Stroke&rft.date=2018-10&rft.volume=49&rft.issue=10&rft.spage=2508-2511&rft.epage=2508-2511&rft.eissn=0039-2499&rft.issn=0039-2499&rft.au=LARSSON,%20S.%20C.&TRAYLOR,%20M.&MISHRA,%20Aniket&HOWSON,%20J.%20M.%20M.&MICHAELSSON,%20K.&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |